UTHR logo

UTHR
United Therapeutics Corp

2,502
Mkt Cap
$24.75B
Volume
831,085.00
52W High
$607.89
52W Low
$266.98
PE Ratio
20.24
UTHR Fundamentals
Price
$564.81
Prev Close
$570.27
Open
$565.00
50D MA
$504.75
Beta
0.45
Avg. Volume
702,386.43
EPS (Annual)
$27.86
P/B
3.47
Rev/Employee
$2.27M
$20,418.98
Loading...
Loading...
News
all
press releases
Top Biotech Stocks To Follow Today - April 4th
Vertex Pharmaceuticals, Danaher, United Therapeutics, argenex, Moderna, Cocrystal Pharma, and Medpace are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool...
MarketBeat·13h ago
News Placeholder
More News
News Placeholder
Element Squared LLC Acquires New Position in United Therapeutics Corporation $UTHR
Element Squared LLC bought a new position in shares of United Therapeutics Corporation (NASDAQ:UTHR - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities...
MarketBeat·22h ago
News Placeholder
Biotech Stocks To Watch Now - April 3rd
Vertex Pharmaceuticals, Danaher, United Therapeutics, argenex, and Moderna are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded companies that research, develop, and commercialize therapies, drugs, diagnostics, and o...
MarketBeat·2d ago
News Placeholder
Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report?
United Therapeutics (UTHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks·2d ago
News Placeholder
CPRX or UTHR: Which Is the Better Value Stock Right Now?
CPRX vs. UTHR: Which Stock Is the Better Value Option?
Zacks·2d ago
News Placeholder
Equities Analysts Offer Predictions for UTHR FY2026 Earnings
United Therapeutics Corporation (NASDAQ:UTHR - Free Report) - Investment analysts at HC Wainwright lifted their FY2026 earnings estimates for shares of United Therapeutics in a note issued to...
MarketBeat·2d ago
News Placeholder
Insider Selling: United Therapeutics (NASDAQ:UTHR) CEO Sells 9,500 Shares of Stock
United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) CEO Martine Rothblatt sold 9,500 shares of the stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $581.63, for a total value of $5,525,485.00. Following the sale, the chief executive officer...
MarketBeat·2d ago
News Placeholder
United Therapeutics (NASDAQ:UTHR) EVP Sells $4,696,721.00 in Stock
United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) EVP Paul Mahon sold 8,300 shares of the business's stock in a transaction on Thursday, April 2nd. The stock was sold at an average price of $565.87, for a total transaction of $4,696,721.00. Following the transaction, the executive...
MarketBeat·2d ago
News Placeholder
United Therapeutics (NASDAQ:UTHR) CFO Sells $5,931,700.00 in Stock
United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) CFO James Edgemond sold 10,000 shares of the business's stock in a transaction dated Monday, March 30th. The stock was sold at an average price of $593.17, for a total transaction of $5,931,700.00. Following the transaction, the chief...
MarketBeat·3d ago
News Placeholder
Insider Selling: United Therapeutics (NASDAQ:UTHR) CEO Sells $5,610,605.00 in Stock
United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) CEO Martine Rothblatt sold 9,500 shares of United Therapeutics stock in a transaction dated Monday, March 30th. The shares were sold at an average price of $590.59, for a total value of $5,610,605.00. Following the sale, the chief...
MarketBeat·3d ago
<
1
2
...
>

Latest UTHR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.